透析用製剤
- 专利权人:
- 扶桑薬品工業株式会社
- 发明人:
- 黒田 純夫
- 申请号：
- JP2008207646
- 公开号：
- JP5258448B2
- 申请日:
- 2008.08.12
- 申请国别(地区):
- JP
- 年份:
- 2013
- 代理人:
- 摘要：
PROBLEM TO BE SOLVED: To provide a drug product for dialysis with which the elution of iron from a manufacturing device and an A agent dissolving device is suppressed in acetic-acid-free dialysate, and to provide the drug product for dialysis which does not cause the decline of ionized Ca in the dialysate and calcium citrate deposition.
SOLUTION: In the drug product for the dialysis containing sodium chloride, potassium chloride, calcium chloride, magnesium chloride, glucose, and sodium hydrogen carbonate as essential components, by using succinic acid and sodium salt of organic acid as a pH adjusting agent and maintaining the pH of an agent A at 2.9-3.6, the problem of iron elution is solved. Further, by using sodium succinate and sodium citrate together, the problems of the decline of ionized Ca, calcium citrate deposition, and calcium carbonate deposition generated in the dialysate are solved.
COPYRIGHT: (C)2010,JPO&INPIT
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Mosapride citrate sustained-release matrix formulation dispersed by pellet and preparing the method thereof
- Artificial bone material having controlled calcium ion elution
- METHOD FOR PRODUCING PEPTIDE FRACTIONS AND USE THEREOF
- Artificial bone material having controlled calcium ion elution
- DEVICE FOR IN VIVO DELIVERY OF BIOACTIVE AGENTS AND METHOD OF MANUFACTURE THEREOF
